BRAF and non-small cell lung carcinoma: While BRAF mutations in NSCLC have been described for several years, the actual prevalence and clinical features of patients with NSCLC who harbor BRAF mutations are not well defined due to the relatively low number of patient cases investigated [14]–[16].